Table 3: NS3/4A protease inhibitors containing IFN-free combination treatment regimens and their treatment recommendations as per genotype
adapted from EASL Recommendations on Treatment of Hepatitis C 2016 [14]
Table 3: NS3/4A protease inhibitors containing IFN-free combination treatment regimens and their treatment recommendations as per genotype
adapted from EASL Recommendations on Treatment of Hepatitis C 2016 [14]